Non-pharmaceutical treatment combats recurring Clostridium Difficile infections
Transplanting human donor fecal microbiota into the colon of a patient infected with Clostridiodes difficile (C. diff) may be the best treatment for those not helped by C. diff targeted antibiotics, according to an article in the Journal of the American Osteopathic Association.
C. diff is the most common healthcare-acquired infection in the United States. It affects nearly half a million patients each year and becomes a recurring infection for nearly a third of them. If untreated, C. diff can lead to sepsis and death.
“Twenty five years ago C. diff infections were easier to manage and often resolved with discontinuation of the initiating antibiotic,” says Robert Orenstein, DO, an infectious disease specialist at Mayo Clinic and lead author on this article. “However, these infections have become increasingly common and pernicious.”
The standard and FDA-approved treatment for C. diff is a course of oral vancomycin, an antibiotic. However, even the medications used to eliminate C. diff can perpetuate the infection by killing off beneficial microbes. Newer antibiotics that more specifically target C. diff have been developed but they can be prohibitively expensive, according to Dr. Orenstein.
“Think of your gut as a forest and C. diff as a weed,” says Dr. Orenstein. “In a thriving forest, weeds barely get a foothold. But if you burn the forest down, the weeds are going to flourish.”
Unlike antibiotics, which are destructive by definition, fecal transplants or microbial replacement therapies, repopulate the gut with a diverse group of microbes that may block the C. diff‘s spore from germinating and propagating disease via its toxins. Transplants have several delivery methods, including enemas, capsules and direct instillation, to replace the diverse flora that maintain health and improve metabolism.
Currently, there are no FDA-approved fecal transplant products and performing fecal transplants is considered an investigational procedure. Dr. Orenstein notes there are several companies with products in Phase 3 clinical trials that could come to market as early as 2020. For this reason he strongly urges healthcare providers to refer patients with recurrent C. diff for these trials rather than for fecal transplants. In the meantime, the FDA reserves fecal transplants for patients who have experienced a second recurrence (third episode) of C. diff infection.
C. diff is common in healthcare settings and public spaces and rarely causes problems in people with healthy gut microbiota and immune systems, according to researchers. However, people who are already ill and taking antibiotics, chemotherapy, or proton pump inhibitors–which all greatly disrupt the gut ecosystem–are at risk. Elderly patients are especially vulnerable.
Dr. Orenstein expects the new treatment options will improve outcomes but says physicians need to assume greater responsibility for prevention.
“One of the most effective things physicians can do is become more responsible with antibiotic prescriptions,” says Dr. Orenstein. “That means only prescribing when they are clearly indicated, not for colds or viral sinus infections. We also must be especially judicious with elderly patients.”
The Latest on: Fecal transplants
via Google News
The Latest on: Fecal transplants
- 8 Best Pet Insurance Companies for Dogs | 2021on August 12, 2021 at 9:29 am
If you own a dog, purchasing a pet insurance policy can ensure it gets the attention it needs during an emergency while also preventing you from paying for expensive vet bills. Keep reading to learn ...
- Gut Microbes Could Make Aging Brains Youthful Againon August 12, 2021 at 4:55 am
Now that scientists can easily determine the composition of a gut microbiome by sequencing the DNA in a stool sample, more and more associations are being | Microbiology ...
- Fecal Transplants May Reverse Brain Aging in Miceon August 11, 2021 at 12:45 pm
Older rodents showed improved cognition and behavior after receiving a microbiome refresh from younger rodents ...
- Poop Transplants From Youngsters Reverse Brain Aging In Miceon August 9, 2021 at 9:45 am
Could poop be the secret to “eternal youth?” It’s perhaps not quite as ridiculous (or gross) as it might sound. As reported in the journal Nature Aging, a ...
- New poo, new you? Fecal transplants reverse signs of brain aging in miceon August 9, 2021 at 8:36 am
P As you age, your brain slows down. You may forget where you left your glasses or have trouble picking up a new skill. Now there’s hope from rodent experiments that some of these declines could be ...
- Gut bacteria from young mice reverse signs of brain aging in old miceon August 8, 2021 at 5:00 pm
The study found fecal transplants from young to old mice reversed some aspects of age-related brain deterioration. An influential 2017 study found fecal transplants from young killfish to older ...
- Fecal Transplants May Help Patients With Crohn’s Disease And Other Intestinal Disorderson August 8, 2021 at 5:00 pm
There are lots of different types of transplants for lots of different medical conditions. One of the newest is called a fecal transplant, where the stool of a healthy individual is transferred to ...
- Dr. Sabine Hazan Conducts ProgenaBiome's First Fecal Transplant for The Purposes of Studying Autismon August 3, 2021 at 12:05 pm
traversed new frontiers in clinical research as she executed her first investigational use of Fecal Microbiota Transplant (FMT) as a potential treatment for an Autism patient last month.
- Creative BioMart Microbe Provides Fecal Microbiota Transplantation Service for Research Useon July 29, 2021 at 5:00 pm
Creative BioMart Microbe, a sub-brand of Creative BioMart that provides microbiological services and products to multi-industry customers, now has been focusing on the development of microbiotherapy, ...
via Bing News